Safety of cardiovascular disease drugs approved between 2014 and 2021 in the US: a pharmacovigilance analysis.

Published in: Expert review of cardiovascular therapy (2024)

This study identified specific safety concerns related to recently approved CVD drugs. Further research is required to understand the underlying mechanisms and clinical implications of these findings.

Keyphrases

cardiovascular disease
drug induced
drug administration
type diabetes
adverse drug
metabolic syndrome
cardiovascular events
electronic health record